NKTR – nektar therapeutics (US:NASDAQ)
Stock Stats
News
Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR) [Yahoo! Finance]
Nektar Therapeutics: Rezpeg's Phase 2b Alopecia Areata Results Leave Many Questions [Seeking Alpha]
Why Analysts Think Nektar Therapeutics Could Be Undervalued After Rezpeg Trial Momentum Grows [Yahoo! Finance]
Nektar Therapeutics (NASDAQ:NKTR) had its price target raised by analysts at BTIG Research from $100.00 to $118.00. They now have a "buy" rating on the stock.
Nektar Therapeutics (NASDAQ:NKTR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Form 4 NEKTAR THERAPEUTICS For: Dec 22 Filed by: Zalevsky Jonathan
Form 4 NEKTAR THERAPEUTICS For: Dec 22 Filed by: ROBIN HOWARD W
Form 8-K NEKTAR THERAPEUTICS For: Dec 16
Form 4 NEKTAR THERAPEUTICS For: Nov 21 Filed by: Zalevsky Jonathan
Form 4 NEKTAR THERAPEUTICS For: Nov 21 Filed by: Wilson Mark Andrew
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.